申请人:KALVISTA PHARMACEUTICALS LTD
公开号:WO2014188211A1
公开(公告)日:2014-11-27
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B,W, X, Y and Z are as defined herein.
本发明提供了化合物的结构公式(I):包含这些化合物的组合物;在治疗中使用这些化合物(例如,在涉及血浆激肽酶活性的疾病或症状的治疗或预防中);以及使用这些化合物治疗患者的方法;其中R5、R6、R7、A、B、W、X、Y和Z如本文所定义。